Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Ethereum could reach $250,000 as AI and tokenization boost demand, says Tom Lee of Fundstrat.

Market News
03 Jun 2026
Blockonomi
View Source
Bullish
pluang ai news

Tom Lee of Fundstrat predicts Ethereum's price could soar to $250,000, driven by AI integration and asset tokenization trends. His firm Bitmine recently bought 111,942 ETH, increasing its holdings to 5.4 million ETH, about 4.47% of the supply. Corporate validators now control 7% of Ethereum, earning over $500 million annually from staking, while the Ethereum Foundation's holdings have dropped to 0.1%. Lee highlights Ethereum's role in enabling machine-driven economies and anticipates significant network value growth. ETH was priced at $1,906, down 6% in 24 hours at the time of reporting.

More News

Clear Junction and Agant partner to enable institutional access to sterling stablecoin GBPA

Clear Junction and Agant partner to enable institutional access to sterling stablecoin GBPA

Clear Junction Group and Agant have partnered to facilitate institutional access to GBPA, a Pound sterling-backed stablecoin designed for practical financial use. This partnership connects fiat GBP payment flows with GBPA issuance and redemption, tar...

Market News
Bullish
54 minutes ago
Brand Licensing Europe 2026 set for record exhibitor growth and visitor registration now open

Brand Licensing Europe 2026 set for record exhibitor growth and visitor registration now open

Brand Licensing Europe (BLE) 2026, scheduled for October 6-8 at Excel London, is poised to be its largest event yet with a 16% increase in exhibitors compared to last year. Following a record-breaking 2025 event that attracted over 11,000 visitors, B...

Market News
Bullish
54 minutes ago
NRx Pharmaceuticals shares drop 19% after announcing a public stock offering.

NRx Pharmaceuticals shares drop 19% after announcing a public stock offering.

NRx Pharmaceuticals' stock fell 19.05% in after-hours trading following the announcement of a proposed underwritten public offering of common stock. The company plans to use the proceeds for working capital and general corporate purposes to support g...

Company Fundamentals
Bearish
2 hours ago
Sigenergy launches SigenAgent AI to optimize solar, storage, and EV charging globally via app upgrade.

Sigenergy launches SigenAgent AI to optimize solar, storage, and EV charging globally via app upgrade.

Sigenergy has introduced SigenAgent, an AI-driven energy management system designed to optimize solar power, energy storage, and electric vehicle charging. Available globally through the mySigen App 4.0 as a software upgrade, SigenAgent allows users ...

Others
Bullish
3 hours ago
Nipocalimab shows sustained reduction in lupus disease activity in Phase 2 study, advancing to Phase 3 trials.

Nipocalimab shows sustained reduction in lupus disease activity in Phase 2 study, advancing to Phase 3 trials.

Johnson & Johnson's investigational drug nipocalimab significantly reduced disease activity in adults with moderate-to-severe systemic lupus erythematosus (SLE) during a Phase 2 study, with effects sustained through 52 weeks. The drug targets pathoge...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App